Bio Essence Corporation
BIOE
$0.18
-$0.07-27.96%
OTC PK
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 2.38M | 1.90M | 565.70K | 563.60K | 346.20K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 2.38M | 1.90M | 565.70K | 563.60K | 346.20K |
| Cost of Revenue | 648.70K | 469.10K | 173.80K | 186.50K | 108.50K |
| Gross Profit | 1.73M | 1.43M | 391.90K | 377.10K | 237.70K |
| SG&A Expenses | 406.30K | 528.40K | 517.60K | 663.50K | 750.30K |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 1.05M | 997.50K | 691.40K | 850.00K | 858.80K |
| Operating Income | 1.32M | 900.00K | -125.70K | -286.40K | -512.60K |
| Income Before Tax | 1.32M | 897.00K | -159.70K | -1.37M | -1.65M |
| Income Tax Expenses | 10.60K | 800.00 | 800.00 | 800.00 | 800.00 |
| Earnings from Continuing Operations | 1.31 | 0.90 | -0.16 | -1.37 | -1.65 |
| Earnings from Discontinued Operations | -- | -- | 0.00 | 0.00 | 0.00 |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 1.31M | 896.20K | -160.50K | -1.37M | -1.65M |
| EBIT | 1.32M | 900.00K | -125.70K | -286.40K | -512.60K |
| EBITDA | 1.32M | 900.30K | -125.30K | -286.00K | -512.00K |
| EPS Basic | 0.03 | 0.02 | 0.00 | -0.04 | -0.04 |
| Normalized Basic EPS | 0.02 | 0.01 | 0.00 | -0.02 | -0.03 |
| EPS Diluted | 0.06 | 0.05 | 0.00 | -0.04 | -0.04 |
| Normalized Diluted EPS | 0.02 | 0.01 | 0.00 | -0.02 | -0.03 |
| Average Basic Shares Outstanding | 158.98M | 152.04M | 152.04M | 152.04M | 152.04M |
| Average Diluted Shares Outstanding | 158.98M | 152.04M | 152.04M | 152.04M | 152.04M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |